Edesa Biotech Extends COVID-19 Clinical Study to Poland

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/12/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. ALP
8. SKHYV
9. NVDA
10. NRIX

Go back to Edesa Biotech Extends COVID-19 Clinical Study to Poland
(NASDAQ: EDSA) Delayed: 7.01 -0.01 (0.14%)
Previous Close $7.02    52 Week High $ 
Open $6.91    52 Week Low $ 
Day High $7.24    P/E N/A 
Day Low $6.91    EPS $ 
Volume 50,607